GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Deferred Policy Acquisition Costs

Poxel (XPAR:POXEL) Deferred Policy Acquisition Costs


View and export this data going back to 2015. Start your Free Trial

What is Poxel Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Poxel (XPAR:POXEL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Deferred Policy Acquisition Costs
Traded in Other Exchanges
N/A
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.